Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | Zendy

Alp Aytekin | Zendy; Gjin Ndrepepa | Zendy; FranzJosef Neumann | Zendy; Maurizio Menichelli | Zendy; Katharina Mayer | Zendy; Jochen Wöhrle | Zendy; Isabell Bernlochner | Zendy; Shqipdona Lahu | Zendy; Gert Richardt | Zendy; Bernhard Witzenbichler | Zendy; Dirk Sibbing | Zendy; Salvatore Cassese | Zendy; Dominick J. Angiolillo | Zendy; Christian Valina | Zendy; Sebastian Kufner | Zendy; Christoph Liebetrau | Zendy; Christian W. Hamm | Zendy; Erion Xhepa | Zendy; Alexander Hapfelmeier | Zendy; Hendrik B. Sager | Zendy; Isabel Wustrow | Zendy; Michael Joner | Zendy; Dietmar Trenk | Zendy; Massimiliano Fusaro | Zendy; KarlLudwig Laugwitz | Zendy; Heribert Schunkert | Zendy; Stefanie Schüpke | Zendy; Adnan Kastrati | Zendy

Open Access

Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Author(s) -

Alp Aytekin,

Gjin Ndrepepa,

FranzJosef Neumann,

Maurizio Menichelli,

Katharina Mayer,

Jochen Wöhrle,

Isabell Bernlochner,

Shqipdona Lahu,

Gert Richardt,

Bernhard Witzenbichler,

Dirk Sibbing,

Salvatore Cassese,

Dominick J. Angiolillo,

Christian Valina,

Sebastian Kufner,

Christoph Liebetrau,

Christian W. Hamm,

Erion Xhepa,

Alexander Hapfelmeier,

Hendrik B. Sager,

Isabel Wustrow,

Michael Joner,

Dietmar Trenk,

Massimiliano Fusaro,

KarlLudwig Laugwitz,

Heribert Schunkert,

Stefanie Schüpke,

Adnan Kastrati

Publication year - 2020

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.120.050244

Subject(s) - medicine , prasugrel , ticagrelor , myocardial infarction , percutaneous coronary intervention , cardiology , clinical endpoint , hazard ratio , timi , randomized controlled trial , confidence interval

Data on the comparative efficacy and safety of ticagrelor versus prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention are limited. We assessed the efficacy and safety of ticagrelor versus prasugrel in a head-to-head comparison in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research